Biogen Shares Rise After Positive Litifilimab Phase 2 CLE Data Biogen reported a second positive Phase 2 litifilimab result at Week 16; data presented Mar 28, 2026 (source: Business Insider/GlobeNewswire).

Biogen Shares Rise After Positive Litifilimab Phase 2 CLE Data: Biogen reported a second positive Phase 2 litifilimab result at Week 16; data presented Mar 28, 2026 (source: Business Insider/GlobeNewswire). 👈 Read full analysis #Biogen #Litifilimab #Phase2ClinicalTrial #Pharmaceuticals #Healthcare